425 related articles for article (PubMed ID: 35132912)
1. The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking.
Zhu W; Li Y; Zhao J; Wang Y; Li Y; Wang Y
Ann Med; 2022 Dec; 54(1):541-552. PubMed ID: 35132912
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K/Akt, apoptosis, and TNF-α signalling pathways.
Zhu W; Wang Y; Liu C; Wu Y; Li Y; Wang Y
Front Pharmacol; 2022; 13():990760. PubMed ID: 36419618
[No Abstract] [Full Text] [Related]
3. Exploration of the Mechanism of Tripterygium Wilfordii in the Treatment of Myocardial Fibrosis Based on Network Pharmacology and Molecular Docking.
Ming Y; Jiachen L; Tao G; Zhihui W
Curr Comput Aided Drug Des; 2023; 19(1):68-79. PubMed ID: 36306461
[TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology and Molecular Docking Analysis Exploring the Mechanism of
Huang W; Huang X; Yang L; Han W; Zhu Z; Wang Y; Chen R
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629739
[No Abstract] [Full Text] [Related]
5. Triptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment.
Wang F; An SJ; Yin Y; Li JJ; Sun CH; Lan J; Zhao WJ; Li CQ
Drug Des Devel Ther; 2021; 15():4275-4287. PubMed ID: 34703209
[TBL] [Abstract][Full Text] [Related]
6. Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking.
Zhu N; Huang B; Zhu L; Wang Y
J Diabetes Res; 2021; 2021():9944589. PubMed ID: 34926700
[TBL] [Abstract][Full Text] [Related]
7. Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Molecular Mechanism of Triptolide in the Treatment of Membranous Nephropathy.
Zhang PN; Tang JY; Yang KZ; Zheng QY; Dong ZC; Geng YL; Liu YN; Liu WJ
Drug Des Devel Ther; 2022; 16():4061-4076. PubMed ID: 36448035
[TBL] [Abstract][Full Text] [Related]
8. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking.
Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z
Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560
[TBL] [Abstract][Full Text] [Related]
9. Prediction of triptolide targets in rheumatoid arthritis using network pharmacology and molecular docking.
Song X; Zhang Y; Dai E; Wang L; Du H
Int Immunopharmacol; 2020 Mar; 80():106179. PubMed ID: 31972422
[TBL] [Abstract][Full Text] [Related]
10. Integrating network pharmacology and experimental verification to explore the mechanism of Tripterygium wilfordii in ankylosing spondylitis.
Chen Y; Liu Z; Yu Q; Qu X; Liu H
Medicine (Baltimore); 2023 Dec; 102(50):e36580. PubMed ID: 38115356
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology and in vivo studies reveal the pharmacological effects and molecular mechanisms of Celastrol against acute hepatic injury induced by LPS.
Yang T; Zhao S; Sun N; Zhao Y; Wang H; Zhang Y; Hou X; Tang Y; Gao X; Fan H
Int Immunopharmacol; 2023 Apr; 117():109898. PubMed ID: 36827925
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the anti-aging mechanism of Si Jun Zi Tang by integrating network pharmacology and experimental validation
Yuan Y; Zhang Y; Zheng R; Yuan H; Zhou R; Jia S; Liu J
Aging (Albany NY); 2022 May; 14(9):3941-3955. PubMed ID: 35537009
[TBL] [Abstract][Full Text] [Related]
13. Study on the Potential Mechanism of Tonifying Kidney and Removing Dampness Formula in the Treatment of Postmenopausal Dyslipidemia Based on Network Pharmacology, Molecular Docking and Experimental Evidence.
Li X; Chen H; Yang H; Liu J; Li Y; Dang Y; Wang J; Wang L; Li J; Nie G
Front Endocrinol (Lausanne); 2022; 13():918469. PubMed ID: 35872979
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
Zhao J; Lin F; Liang G; Han Y; Xu N; Pan J; Luo M; Yang W; Zeng L
Front Endocrinol (Lausanne); 2021; 12():815891. PubMed ID: 35069454
[TBL] [Abstract][Full Text] [Related]
15. [Advanced progress of main pharmacology activities of triptolide].
Cui J; Chen X; Su JC
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2655-2658. PubMed ID: 29098818
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of Mahuang Lianqiao Chixiaodou Decoction in treating eczema by network pharmacology and molecular docking technology].
Zhang XW; Liu AM; Zhao JJ; Guo J; Chen XY; Qu XX
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):894-901. PubMed ID: 33645094
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of
Wu WY; Jiao X; Song WX; Wu P; Xiao PQ; Huang XF; Wang K; Zhan SF
Front Endocrinol (Lausanne); 2023; 14():1187882. PubMed ID: 37347115
[TBL] [Abstract][Full Text] [Related]
18. Triptolide: progress on research in pharmacodynamics and toxicology.
Li XJ; Jiang ZZ; Zhang LY
J Ethnopharmacol; 2014 Aug; 155(1):67-79. PubMed ID: 24933225
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the Potential Mechanism of Triptolide in Improving Diabetic Nephropathy by Utilizing A Network Pharmacology and Molecular Docking Approach.
An X; Fan D; Yin Z; Zhang J; Zhou Y; Tian R; Yan M
Front Biosci (Landmark Ed); 2022 Mar; 27(3):94. PubMed ID: 35345326
[TBL] [Abstract][Full Text] [Related]
20. Study on the mechanism of ErtongKe granules in the treatment of cough using network pharmacology and molecular docking technology.
Chen YL; Li WX; Zhang H; Wang XY; Zhang SQ; Zhang ML; Han J; Li K; Feng KR; Chen XF; Tang JF
Ann Palliat Med; 2021 Nov; 10(11):11415-11429. PubMed ID: 34872267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
